Projects funded by the NCN

Development of optimization methods for dose selection of analgesic drugs used as a combination drug therapy in neuropat...

Call: OPUS 9 , Panel: NZ7

Principal investigator: dr hab. Kinga Sałat

Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny

Anticancer activity of the thiosemicarbazone derivatives

Call: SONATA 7 , Panel: NZ7

Principal investigator: dr Anna Dominika Mrozek-Wilczkiewicz

Uniwersytet Śląski w Katowicach, Wydział Matematyki, Fizyki i Chemii

Combination therapy with naphthoquinones and paclitaxel in the pharmacological induction of cell death in breast cancer ...

Call: OPUS 2 , Panel: NZ7

Principal investigator: dr Anna Kawiak

Uniwersytet Gdański

"Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud...

Call: OPUS 28 , Panel: NZ7

Principal investigator: prof. Gabriel Piotr Nowak

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Assessment of virulence, biofilm formation and drug-susceptibility of Candida albicans treated with plant essential oils...

Call: PRELUDIUM 1 , Panel: NZ6

Principal investigator: Aleksandra Budzyńska

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Design and implementation of effective cOmbination of Phages and Antibiotics for improved TheRApy protocols against KLEb...

Call: WEAVE-UNISONO , Panel: NZ6

Principal investigator: prof. Zuzanna Drulis-Kawa

Uniwersytet Wrocławski

Bioresorbable, electrospun nonwoven as a multi-drug delivery system for a combination glioblastoma therapy

Call: SONATA 17 , Panel: NZ7

Principal investigator: dr Monika Anna Musiał-Kulik

Centrum Materiałów Polimerowych i Węglowych Polskiej Akademii Nauk

In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno...

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: Anna Karolina Pogorzelska

Narodowy Instytut Leków

Drug repurposing to target p53 protein family for improved therapy in the relapsed TP53 and EGFR mutated lung cancer

Call: OPUS 20 , Panel: NZ7

Principal investigator: dr Joanna Elżbieta Zawacka-Pankau

Warszawski Uniwersytet Medyczny

Evaluation of the activity of MDM2-p53 antagonist RG7388 in mouse cancer models, alone and in combination with anti-PD-1...

Call: PRELUDIUM 18 , Panel: NZ5

Principal investigator: Aneta Sylwia Nieznańska

Uniwersytet Jagielloński, Wydział Chemii

The combination of radiotherapy with imiquimod and sunitinib as a new therapeutic strategy overcoming some of the tumor ...

Call: SONATA 14 , Panel: NZ5

Principal investigator: dr Magdalena Jarosz-Biej

Narodowy lnstytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy lnstytut Badawczy, Oddział w Gliwicach

Old drugs - new perspectives: modulation of antibiotics activity by caffeine and pentoxifylline

Call: SONATA 11 , Panel: NZ7

Principal investigator: dr Anna Woziwodzka

Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

Evaluation of novel, synergistic drug combinations for the treatment of B cell malignancies

Call: OPUS 11 , Panel: NZ7

Principal investigator: dr Małgorzata Firczuk

Warszawski Uniwersytet Medyczny, Wydział Lekarski

The role of DNA methylation in enhancing the sensitivity of colorectal cancer cells to topoisomerase inhibitors.

Call: PRELUDIUM 9 , Panel: NZ3

Principal investigator: Alicja Patrycja Pawlak

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk